However, last year, the testing process was changed to reduce the cost of testing well- established products, which we at Head Office had been concerned to see rising. Remedium issued a directive to all its subsidiaries involved in the manufacture of generics requiring them to carry out testing in accordance with Remedium Group's Revised Testing Protocols, issued by the Health and Safety Committee of the Remedium Board. A class action claim has now been received from a number of patients who claim that Deepair has caused them breathing difficulties. The allegation is that the changes brought about by the new Protocols have resulted in products being manufactured by Farlung with impurities which have exacerbated the claimants' existing conditions. We have instructed experts to investigate the merits of the actual claims, but would like some advice from you on who might be potential defendants in the matter. We are concerned that, if too many more of these claims come to light, Farlung will not be able to meet them all, as it will go over and above its insurance excess. Thanks, Kleb